Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2001 1
2002 2
2003 1
2005 2
2007 1
2008 1
2012 1
2013 2
2014 3
2015 3
2016 3
2017 3
2018 6
2019 2
2020 6
2021 14
2022 9
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Response.
Zasowski EJ, Bassetti M, Blasi F, Rello J, Sotgiu G, Tavoschi L, Arber MR, McCool R, Patterson JV, Longshaw CM, Lopes S, Manissero D, Nguyen ST, Tone K, Aliberti S. Zasowski EJ, et al. Among authors: longshaw cm. Chest. 2021 Apr;159(4):1677-1678. doi: 10.1016/j.chest.2020.11.029. Epub 2021 Apr 6. Chest. 2021. PMID: 34021997 Free article. No abstract available.
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.
Guery B, Menichetti F, Anttila VJ, Adomakoh N, Aguado JM, Bisnauthsing K, Georgopali A, Goldenberg SD, Karas A, Kazeem G, Longshaw C, Palacios-Fabrega JA, Cornely OA, Vehreschild MJGT; EXTEND Clinical Study Group. Guery B, et al. Among authors: longshaw c. Lancet Infect Dis. 2018 Mar;18(3):296-307. doi: 10.1016/S1473-3099(17)30751-X. Epub 2017 Dec 19. Lancet Infect Dis. 2018. PMID: 29273269 Clinical Trial.
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins.
Wagenlehner F, Lucenteforte E, Pea F, Soriano A, Tavoschi L, Steele VR, Henriksen AS, Longshaw C, Manissero D, Pecini R, Pogue JM. Wagenlehner F, et al. Among authors: longshaw c. Clin Microbiol Infect. 2021 Jan 6:S1198-743X(20)30764-3. doi: 10.1016/j.cmi.2020.12.009. Online ahead of print. Clin Microbiol Infect. 2021. PMID: 33359542 Free article. Review.
Placing in-vitro heteroresistance in the context of clinical results.
Bassetti M, Echols R, Koren A, Karas A, Longshaw C, Yamano Y, Den Nagata T. Bassetti M, et al. Among authors: longshaw c. Lancet Infect Dis. 2021 Jul;21(7):908-909. doi: 10.1016/S1473-3099(21)00328-5. Lancet Infect Dis. 2021. PMID: 34174228 No abstract available.
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations.
Santerre Henriksen A, Jeannot K, Oliver A, Perry JD, Pletz MW, Stefani S, Morrissey I, Longshaw C; ARTEMIS Study Investigators. Santerre Henriksen A, et al. Among authors: longshaw c. Microbiol Spectr. 2024 Apr 2;12(4):e0383623. doi: 10.1128/spectrum.03836-23. Epub 2024 Mar 14. Microbiol Spectr. 2024. PMID: 38483164 Free PMC article.
59 results